Filtered by speaker:Chris Clark×
Searching...
3 results for “biotech moats” by Chris Clark
Concept3 mentions across episodes
moats
...within biotech? I I feel like, you know, you see certain product pipelines and ideas and developments or anything you particularly would avoid as well. Well, in general, you're looking for low capital intensive, predictable results. So what we would,
1:12:53 / 1:13:51
from transcript1:12:53 – 1:13:51
...biotech with the asymmetric outcomes, god bless them. But really what they're what a lot of them are doing are creating their own custom benchmarks to then to then judge their long portfolio against. And it's a source of capital. You know, I don't ne
1:33:48 / 1:34:52
from transcript1:33:48 – 1:34:52
Have a podcast?
Run your podcast through Clypt
Get ranked clips, hooks, and ready-to-post copy from your own episodes. Free to try.